Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT04306900 2025-07-29

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

Phase 1 Completed

185 enrolled 28 charts

GastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Clinical Trials

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Intravesical Gem/Doce in Patients With NMIBC

TroFuse-031

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

GEMDOCE

Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

KEYVIBE-005

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers